Primo Chemicals Acquires Remaining 51% Stake in FlowTech, to be Wholly Owned Subsidiary
Primo Chemicals Limited's Board approved acquiring the remaining 51% stake in FlowTech Chemicals Private Limited, making it a wholly-owned subsidiary. The company also approved the appointment of two independent directors and remuneration for key management personnel. E-voting for member approval will occur from July 7 to August 5, 2026. The acquisition is expected to be completed by March 31, 2027.
The acquisition will increase Primo Chemicals' control over FlowTech, which is a significant step. However, the financial impact details are not fully elaborated, and the transaction is subject to shareholder approval, limiting the immediate high impact.
The acquisition of a remaining stake to make a subsidiary wholly owned is generally positive, indicating consolidation and increased control, which is expected to lead to strategic and financial benefits.
Primo Chemicals Limited announced that its Board of Directors, in a meeting held on July 2, 2026, approved the acquisition of the remaining 51% equity stake in FlowTech Chemicals Private Limited (FlowTech). This acquisition will make FlowTech a 100% wholly-owned subsidiary of Primo Chemicals, subject to member approval. The company had previously acquired a 49% stake in FlowTech, classifying it as an associate company.
The Board also approved a Postal Ballot Notice for seeking member approval on several resolutions, including the appointment of Shri Dibakar Sarkar and Shri Sobhag Mal Jain as Non-Executive Independent Directors, the acquisition of the balance 51% stake in FlowTech, and the approval of remuneration for the Managing Director, Shri Naveen Chopra, and Executive Director, Shri Jatin Dahiya, for their remaining tenures.
The cut-off date for determining eligibility for voting has been fixed as July 3, 2026. The e-voting period will commence on July 7, 2026, and conclude on August 5, 2026.
FlowTech Chemicals Private Limited, incorporated in 1996, is engaged in the manufacture of Chlorinated Paraffin and Hydrochloric Acid. In the financial year 2025-26, FlowTech reported a turnover of ₹341.66 crore (34166.14 lakhs) and a Profit After Tax (PAT) of ₹9.80 crore (979.58 lakhs). The acquisition is expected to enhance strategic and operational control, facilitate business synergies, and generate long-term operational and financial benefits. The acquisition is expected to be completed by March 31, 2027, with the shares being acquired at a consideration of ₹1,418.20 per equity share, despite a valuation report indicating a fair value of ₹1,545.40 per equity share.
What to do with a filing like this
Primo Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Primo Chemicals Limited. Read the original for the full detail.